These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31201287)

  • 1. GI infections are associated with an increased risk of Parkinson's disease.
    Nerius M; Doblhammer G; Tamgüney G
    Gut; 2020 Jun; 69(6):1154-1156. PubMed ID: 31201287
    [No Abstract]   [Full Text] [Related]  

  • 2. The Gut and Nonmotor Symptoms in Parkinson's Disease.
    Klingelhoefer L; Reichmann H
    Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the gut be the missing piece in uncovering PD pathogenesis?
    Chapelet G; Leclair-Visonneau L; Clairembault T; Neunlist M; Derkinderen P
    Parkinsonism Relat Disord; 2019 Feb; 59():26-31. PubMed ID: 30448099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut in Parkinson's disease: Bottom-up, top-down, or neither?
    Leclair-Visonneau L; Neunlist M; Derkinderen P; Lebouvier T
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13777. PubMed ID: 31854093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment approaches of gastrointestinal dysfunction in Parkinson's disease, therapeutical options and future perspectives.
    Woitalla D; Goetze O
    J Neurol Sci; 2011 Nov; 310(1-2):152-8. PubMed ID: 21798561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
    O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut-brain axis and gut inflammation in Parkinson's disease: stopping neurodegeneration at the toll gate.
    Gorecki AM; Dunlop SA; Rodger J; Anderton RS
    Expert Opin Ther Targets; 2020 Jul; 24(7):601-604. PubMed ID: 32349553
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.
    Manfredsson FP; Luk KC; Benskey MJ; Gezer A; Garcia J; Kuhn NC; Sandoval IM; Patterson JR; O'Mara A; Yonkers R; Kordower JH
    Neurobiol Dis; 2018 Apr; 112():106-118. PubMed ID: 29341898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System.
    Obata Y; Pachnis V
    Gastroenterology; 2016 Nov; 151(5):836-844. PubMed ID: 27521479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease.
    Ghaisas S; Langley MR; Palanisamy BN; Dutta S; Narayanaswamy K; Plummer PJ; Sarkar S; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2019 Dec; 75():186-199. PubMed ID: 31505196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enteric nervous system and Parkinson's disease].
    Paillusson S; Lebouvier T; Pouclet H; Coron E; Bruley des Varannes S; Damier P; Neunlist M; Derkinderen P
    Rev Med Interne; 2012 Jun; 33(6):335-8. PubMed ID: 22318211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.
    van IJzendoorn SCD; Derkinderen P
    J Parkinsons Dis; 2019; 9(s2):S323-S329. PubMed ID: 31561386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects and pathophysiological significance of intestinal flora on the enteric neuro-endocrine-immune system].
    Xu HN; Cai ZZ; Wang Y; Wu DE; Rong WF; Zhang GH
    Sheng Li Xue Bao; 2020 Jun; 72(3):347-360. PubMed ID: 32572432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
    Follmer C
    Mov Disord; 2020 Sep; 35(9):1495-1496. PubMed ID: 32822087
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second brain and Parkinson's disease.
    Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
    Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Commensal Microbiota on the Enteric Nervous System and Its Role in Neurodegenerative Diseases.
    Endres K; Schäfer KH
    J Innate Immun; 2018; 10(3):172-180. PubMed ID: 29742516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.